Danaher Corporation $DHR Stock Position Lessened by Defender Capital LLC.

Key Points

• Defender Capital reduced its Danaher stake by 5.6% in the second quarter, selling 8,813 shares and retaining 148,716 shares valued at approximately $28.3 million. Danaher represents about 9.2% of the firm’s portfolio, while institutional investors collectively own 79.05% of DHR.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $228.91. Recent target changes were mixed, including an RBC increase to $215 and reductions from UBS, Baird, and Morgan Stanley.
• Danaher reported quarterly EPS of $1.94, surpassing estimates of $1.85, while revenue rose 5.5% year over year to $6.26 billion. The stock opened at $208.92, up 2.0%, with a market capitalization of about $146.9 billion.

Defender Capital LLC. cut its stake in Danaher Corporation (NYSE:DHR - Free Report) by 5.6% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 148,716 shares of the conglomerate's stock after selling 8,813 shares during the quarter. Danaher comprises about 9.2% of Defender Capital LLC.'s holdings, making the stock its 4th largest position. Defender Capital LLC.'s holdings in Danaher were worth $28,327,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. JPL Wealth Management LLC purchased a new position in Danaher during the 3rd quarter valued at about $25,000. Main Street Group LTD bought a new stake in shares of Danaher during the first quarter valued at about $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter worth about $26,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the fourth quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. Royal Bank Of Canada upped their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. UBS Group cut their price target on shares of Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. Robert W. Baird reduced their price target on shares of Danaher from $251.00 to $249.00 and set an "outperform" rating for the company in a research report on Friday, April 17th. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 22nd. Finally, Wolfe Research lowered Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.

Danaher Stock Up 2.0%

DHR stock opened at $208.92 on Tuesday. The company's 50 day moving average is $191.24 and its 200 day moving average is $193.84. The stock has a market cap of $146.87 billion, a price-to-earnings ratio of 37.11, a price-to-earnings-growth ratio of 2.55 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the business posted $0.77 earnings per share. Danaher's revenue for the quarter was up 5.5% on a year-over-year basis. Sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source